Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer

This study has been completed.

Study NCT00060242 Information provided by Case Comprehensive Cancer Center

First Received: May 6, 2003 Last Updated: June 10, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2008
Primary Completion Date:	February 2007 (Final data collection date for primary outcome measure)

Publications:

Mooney CJ, Nagaiah G, Fu P, Wasman JK, Cooney MM, Savvides PS, Bokar JA, Dowlati A, Wang D, Agarwala SS, Flick SM, Hartman PH, Ortiz JD, Lavertu PN, Remick SC. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009 Mar;19(3):233-40.

Back to top of Main Content